Farallon Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Farallon Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-66,520	Closed	-$1.53M	–	321
2021 Q3	$1.53M	Sell	66,520 -255,023	-79%	-$7.59M	0.01%	214
2021 Q2	$14.1M	Hold	321,543	–	–	0.06%	117
2021 Q1	$23.3M	Buy	+321,543	New	+$22.8M	0.12%	100

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Farallon Capital Management's ORTX Position: Q4 2021 in Review

Farallon Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 66,520 shares — an estimated $1.53M sold.

Farallon Capital Management first reported a position in ORTX in Q1 2021 and held it in 3 quarters. The position peaked at $23.3M in Q1 2021. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Farallon Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Farallon Capital Management sold 66,520 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $1.53M.
Farallon Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q1 2021 and held it in 3 quarters.
Farallon Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $23.3M in Q1 2021.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Farallon Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.